Hammarskiöld advised MedCap AB (publ) on its acquisition of 51.1% of Inpac and AirContainer respectively through a new parent company. Inpac’s and AirContainer’s respective previous owners have re-invested in the new company group.
Inpac and AirContainer together offer a wide range of packaging solutions for pharmaceutical and probiotics. The focus following the investment is to further develop the packaging offering within probiotics and validated solutions within distribution of temperature sensitive goods.
Hammarskiöld’s team consisted of:
Evelina Olsson (Senior Associate)